IGF1 and Hepatic fibrosis: Recently, engineered human umbilical cord perivascular cell (HUCPVC)-derived EVs have been shown to produce insulin-like growth factor-I (IGF-I) upon their administration, reducing hepatic fibrosis in mice [70].